Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Valirx Plc | VAL | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.025 | -4.17% | 0.575 | 08:39:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.60 | 0.575 | 0.60 | 0.575 | 0.60 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 31/12/2024 14:15 by wulber First ever institutional investor from memory?! |
Posted at 27/12/2024 09:43 by pj 1 2 shares where any positive news flow in the new year could trigger a significant re-rate and also look extremely 'cheap' at todays pricesSBTX Skinbiotherapeutics. On paper it probably looks a POS stock. However, FTSE 100 giant Croda has been forward selling its lysate licensed to SBTX for a good few months. There is an official launch by Croda in April so it will be interesting to see if SBTX comment of the initial sales at all (first Revs were confirmed to land before end 2024.) INSG Insig AI. It is difficult to research what it actually does and looks even worse than SBTX and unfunded. High profile investors such as Richard Bernstein ((now CEO)and Rothchild have stepped in previously so no doubt they will again, although at what price is a concern and always a risk of significant dilution. The FCA will have to start actioning its own ESG regulations at some point and if/when they do, then INSG will benefit as a sort of ''key supplier'' for the data and information. Proactive institutions will be preparing though at least.... Off course the risk is that the FCA (and overseas regulators) sit on thier hands for another 2 years... |
Posted at 12/12/2024 14:39 by rainmaker Fairly confident that Cavendish Financial(CAV)currenExpect the IC to discuss a very lowly rated Company trading at around book value on a price/sales ratio of just 0.9 times with a strong balance sheet with £23mln against a market cap of circa £38mln but trading profitably and cash generative in their second half with a healthy pipeline of business. With over 200 Corporate Clients and the largest broker by a country mile,Cavendish Financial dominate the fast growing Junior Stock market for entrepreneurial and fast growing Companies, The Alternative Investment market(AIM).The listing and maintenance costs, are substantially less than the Main Market and subject to light touch regulation with less bureaucracy and low barriers to entry ie Companies only need a three year trading history to join.They could also discuss AIM companies migrating to the main market-there are currently some 13 Companies originally from AIM in The FTSE 350. There are also continuing tax breaks for Owners despite ungrounded fears to the contrary that they would be abolished in the Autumn mini budget. They may refer to Numis's research where some 86% of respondents expect a sharp upturn in business. They may make a favourable comparison of Cavendish Financial pitiful valuation v that of Numis who were bought by Deutsche Bank for £410 min in October last year. AIMHO, DYOR as I have done mine. Regards |
Posted at 02/12/2024 01:10 by rainmaker Hi ST,Re multi baggers. In my long experience over the years, that in addition to the important factor of a very low base you mention, there has to be something or a combination of factors that "The Market" has missed,failed to appreciate, simply misundertood or don't have the prequisite skills or knowledge to recognise. Then there are quite a few market "blind spots" that I have witnessed over the years where Investors should but failed miserably to identity great opportunities in the early stages prior to a five/10 fold+ share price rally, sometimes in as little as six months to a year. Furthermore Investors consistently fail to fully appreciate the potential growth in earnings and multi bagger share price returns. As a diehard Stockmarket Value Investor I refuse to pay for growth but invest in Companies where I know there will be strong growth. If you look at this in the context of Cavendish Financial(CAV), they are currently trading on a price/sales ratio of 0.9(ie market cap divided by annual sales) yet the capital market sector trades at an average 3.3 times sales(you can check this at "SimplyWallStreet") so applying that average sector rating to CAV currently 9.50p, gives a share price of 35p, a 268% increase. However since I am confident in a large increase in sales at CAV, from a very low base, I expect this to be a conservative figure. AIMHO, DYOR as I have done mine. Regards |
Posted at 26/11/2024 14:04 by rainmaker I can honestly say that Stockbroker, Cavendish Financial (CAV)currently 10p/11p is the clearest cut and best opportunity with the greatest potential returns to multi bag its share price that I have come across in many,many years.Formed by the merger of Cenkos Securities and Finn Capital, two exceptional businesses. Investors are mistakenly looking at this business in the wrong way-if they looked at it in the right way, they would realise that it is a great opportunity.DYOR, AIMHO regards |
Posted at 19/11/2024 08:23 by qnq do I sense UK retail investors lag behind the American retail!Anyone missing on an opportunity to buy tons of shares for little money for something that could bring in cancer treatment is a big IDIxOt and should not be dabbling with stock. Man you throw away more money on euro millions a year with odds that are practically zero. Buy! Idixots (anyone acting like a UK retail that want to make money without risk as usual ignore the post. |
Posted at 16/10/2024 22:34 by porky9 Hi @David BoomtimeYes,was aware of background history, is what it is. Not seen any evidence of a new co just yet but that’s not to say it’s not a possibility. I would do that in Marks position if I’m totally honest - can you point to any specific evidence to back that up? Meanwhile, he could just use his other existing consultancy business ONCOLYTIKA LTD anyhow. I think we just have to see how events unfold now. I am kind of expecting the presentation to spell out the raise, due to the amount of shares needed to be issued he may have to secure a resolution so makes sense to say a) this is what we need, b) these are the terms. Then it’s down to investors if they want to give him the money I guess |
Posted at 09/10/2024 23:11 by david boomtime This is what will happenMark ecclestone dily will want to consolidate the share price as he will create a psychological mindset for investors. Maybe 20:1. At the placing price of maybe 0.8 this will equate to 16p. The financial expert Ned will then dip his toe. This is a possible outcome. The way the human brain will react to this seeing ‘16p’ will buffer shareholders anger. So so readable. However there is lurking in the shadows the nemesis of justice adam ..take |
Posted at 27/8/2024 15:21 by jasonpugh Genius porky.Would it be possible that porky is an employee of valirx? Could it be that this avatar is constantly posting about placings to in effect psychologically control the investors and psychologically soften the blow? The last thing the board wants is to shock investors with continuous placings. If porky can initiate a reinforcement bias then when the placings come the pressures removed somewhat from the board. DYOR. |
Posted at 19/12/2023 13:18 by neotheone Simple facts are val have not returned any investor ROI in 15 years.Shareholders will not continue supporting much longer. Vals investor pool is niche as I see it and they are putting off their longer term investors with how they are conducting the business. Failed goals and the BODs continued view they are doing well enough to continue milking investors is narrow minded to say the least. Kevin said as they see it they are making good progress and Kathy said it is clear they are doing lots of good work in the background. Sadly investors can not see this reflected in the share price The way I see this playing out is the BOD have a limited window to deliver and if they do not then other than Adam saving their bacon I can not see this continuing for much longer because investors will not support this nonsense anymore. We need some high level management changes and a clear focus on what they plan to deliver and we want more transparency. You can not bite the hand that feeds you because sentiment has changed and investors have had enough now. Plus have some respect Kevin, your arrogance towards investors is shockingly bad, we are not stupid. Yes businesses need to build up but they also need to make a profit. Ask yourself what business does not make a profit in 15 years but is still going today? You are on borrowed time Suzy & Kevin! Mark my words! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
